Literature DB >> 18284839

Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996-2005.

E Mokaddas1, S Ahmad, I Samir.   

Abstract

OBJECTIVE: To determine the incidence and trends of drug resistance among all Mycobacterium tuberculosis strains isolated during a 10-year period in Kuwait.
DESIGN: Drug susceptibility data for M. tuberculosis isolates recovered from all pulmonary and extra-pulmonary tuberculosis (TB) patients in Kuwait from January 1996 to December 2005 were collected and analysed. Patients were divided into Kuwaiti nationals and expatriates. Prior treatment status was not recorded.
RESULTS: From 1996 to 2005, 5399 non-repetitive culture-positive TB cases (56% from pulmonary sites and 44% from extra-pulmonary sites) among 917 (17%) Kuwaiti nationals and 4482 (83%) expatriates were identified throughout Kuwait. Overall resistance rates were as follows: any drug 12.5%, isoniazid (INH) 9.1%; rifampicin (RMP) 1.1%, ethambutol (EMB) 2.0%, streptomycin 4.3% and multidrug resistance (MDR) 0.9%. The resistance rates over the 10-year period remained nearly same. However, significant differences were noted in resistance rates for RMP and MDR among pulmonary vs. extra-pulmonary cases and for any drug, INH and EMB among isolates from Kuwaiti vs. expatriate patients.
CONCLUSIONS: Moderate and stable single drug resistance (<10%) and low MDR rates (<1%) were found among TB cases in Kuwait. These findings highlight the importance of ongoing control measures to limit the development and spread of drug-resistant M. tuberculosis in Kuwait.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18284839

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  21 in total

1.  Discordance between Xpert MTB/RIF assay and Bactec MGIT 960 Culture System for detection of rifampin-resistant Mycobacterium tuberculosis isolates in a country with a low tuberculosis (TB) incidence.

Authors:  Eiman Mokaddas; Suhail Ahmad; Hanaa S Eldeen; Noura Al-Mutairi
Journal:  J Clin Microbiol       Date:  2015-01-21       Impact factor: 5.948

2.  Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB/RIF Assays.

Authors:  Patrick Murray; Charles Cooper; Courtney Maus
Journal:  J Clin Microbiol       Date:  2019-08-26       Impact factor: 5.948

3.  Reply to Murray et al., "Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB/RIF Assays".

Authors:  Eiman M Mokaddas; Suhail Ahmad; Hanaa S Eldeen
Journal:  J Clin Microbiol       Date:  2019-08-26       Impact factor: 5.948

4.  GeneXpert MTB/RIF Is Superior to BBD Max MDR-TB for Diagnosis of Tuberculosis (TB) in a Country with Low Incidence of Multidrug-Resistant TB (MDR-TB).

Authors:  E M Mokaddas; S Ahmad; H S Eldeen
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

5.  Diversity of Nontuberculous Mycobacteria in Kuwait: Rapid Identification and Differentiation of Mycobacterium Species by Multiplex PCR, INNO-LiPA Mycobacteria v2 Assay and PCR Sequencing of rDNA.

Authors:  Suhail Ahmad; Eiman Mokaddas
Journal:  Med Princ Pract       Date:  2019-02-14       Impact factor: 1.927

6.  An Update on the Epidemiological Features of Imported Schistosomiasis and Cystic Echinococcosis in Kuwait, 2010-2018.

Authors:  Mohammad Al-Awadhi; Jamshaid Iqbal; Suhail Ahmad
Journal:  Med Princ Pract       Date:  2021-02-01       Impact factor: 1.927

Review 7.  Epidemiology and treatment of multidrug resistant tuberculosis.

Authors:  Carole D Mitnick; Sasha C Appleton; Sonya S Shin
Journal:  Semin Respir Crit Care Med       Date:  2008-09-22       Impact factor: 3.119

8.  Performance Comparison of GeneXpert MTB/RIF and ProbeTec ET Tests for Rapid Molecular Diagnosis of Extrapulmonary Tuberculosis in a Low TB/MDR-TB Incidence Country.

Authors:  Eiman Mokaddas; Suhail Ahmad; Hanaa Eldeen
Journal:  Med Princ Pract       Date:  2021-02-16       Impact factor: 1.927

9.  Variations in the occurrence of specific rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolates from patients of different ethnic groups in Kuwait.

Authors:  Suhail Ahmad; Noura M Al-Mutairi; Eiman Mokaddas
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

10.  First report of molecular detection of fluoroquinolone resistance-associated gyrA mutations in multidrug-resistant clinical Mycobacterium tuberculosis isolates in Kuwait.

Authors:  Noura M Al-Mutairi; Suhail Ahmad; Eiman Mokaddas
Journal:  BMC Res Notes       Date:  2011-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.